References:
  1. Al-Hakeim, H.K., Al-Rammahi, D.A., Al-Dujaili, A.H., 2015. IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation. J Affect Disord. 15,106-14. http://doi.org/10.1016/j.jad.2015.04.044.
  2. Bacchiega, B.C., Bacchiega, A.B., Usnayo, M.J.G., Bedirian, R., Singh, G., Pinheiro, G.D.C. 2017. Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study. Am Heart J. 6, 1-9.http://doi.org/10.1161/JAHA.116.005038
  3. Ballak, D.B., Stienstra, R., Tack, C.J., Dinarello, C.A., van Diepen, J.A., 2015. IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance. Cytokine. 75, 280-90. http://doi.org/10.1016/j.cyto.2015.05.005.
  4. Barnard, D.F., Gabella, K.M., Kulp, A.C., Parker, A.D., Dugan, P.B., Johnson, J.D., 2019. Sex differences in the regulation of brain IL-1β in response to chronic stress. Psychoneuroendocrinology.103, 203-211. http:// doi.org/ 10.1016/j.psyneuen.2019.01.026.
  5. Beurel, E., Toups, M., Nemeroff, C.B., 2020. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 107, 234-256. http://doi.org/10.1016/j.neuron.2020.06.002.
  6. Bhatt, S., Devadoss, T., Jha, N. K., Baidya, M., Gupta, G., Chellappan, D. K., Singh, S. K., Dua, K., 2022. Targeting inflammation: a potential approach for the treatment of depression. Metab brain dis. https://doi.org/10.1007/s11011-022-01095-1
  7. Bhatt, S., Mahesh, R., Devadoss, T., Jindal, A., 2017. Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6 g) on lipopolysaccharide-induced anxiety models in mice. J Basic Clin Physiol Pharmacol. 28, 101–106. http://doi.org/10.1515/jbcpp-2016-0083.
  8. Birur, B., Amrock, E.M., Shelton, R.C., Li, L., 2017. Sex Differences in the Peripheral Immune System in Patients with Depression. Front psychiatry. 8, 108. https://doi.org/10.3389/fpsyt.2017.00108
  9. Brambilla, F., Monteleone, P., Maj, M., 2004. Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia. J Affect Disord. 78, 273-7. http://doi.org/10.1016/S0165-0327(02)00315-4.
  10. Brown, T.A., Korotitsch, W., Chorpita, B.F. Barlow, D.H., 1997. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res and Ther, 35, 79-89. https://doi.org/10.1348/014466506X158996
  11. Buckley, L.F., Abbate, A., 2018. Interleukin-1 blockade in cardiovascular diseases: a clinical update. Eur. Heart J. 39, 2063–2069. http://doi.org/10.1093.
  12. Bürhan-Çavuşoğlu, P., İscan, E., Güneş, A., Atabey, N., Alkın, T., 2021. Increased telomerase activity in major depressive disorder with melancholic features: Possible role of pro-inflammatory cytokines and the brain-derived neurotrophic factor. Brain Behav Immun Health. 4:100259. http://doi.org/10.1016/j.bbih.2021.100259.
  13. Capuron, L., Fornwalt, F.B., Knight, B.T., Harvey, P.D., Ninan, P.T., Miller, A.H., 2009. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?. J Affect disord. 119, 181–185. https://doi.org/10.1016/j.jad.2009.02.017
  14. Cassano, P., Bui, E., Rogers, A.H., Walton, Z.E., Ross, R., Zeng, M., Nadal-Vicens, M., Mischoulon, D., Baker, A.W., Keshaviah, A., Worthington, J., Hoge, E.A., Alpert, J., Fava M., Wong, K.K., Simon ,N.M., 2017. Inflammatory cytokines in major depressive disorder: A case-control study. Aust N Z J Psychiatry. 51, 23-31. http://doi.org/10.1177/0004867416652736.
  15. Castro, J.P., El-Atat, F.A., McFarlane, S.I., Aneja, A., Sowers, J.R., 2003. Cardiometabolic syndrome: pathophysiology and treatment. Curr Hypertens Rep.5, 393-401. http://doi.org/ 10.1007/s11906-003-0085-y.
  16. Celano, C.M., Huffman, J.C., 2011. Depression and cardiac disease: a review. Cardiol Rev.19,130-42. http://doi.org/ 10.1097/CRD.0b013e31820e8106.
  17. Cilan, H., Oguzhan, N., Unal, A., Turan, T., Koc, A.N., Sipahioglu, M.H., Utas, C., Oymak, O., 2012. Relationship between depression and proinflammatory cytokine levels in hemodialysis patients. Ren Fail. 34, 275-8. http://doi.org/ 10.3109/0886022X.2011.647292.
  18. Dahl, J., Ormstad, H., Aass, H.C., Malt, U.F., Bendz, L.T., Sandvik, L., Brundin, L., Andreassen, O.A., 2014. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology. 45, 77-86. http://doi.org/ 10.1016/j.psyneuen.2014.03.019.
  19. Dantzer, R., O’Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46–56. http://doi.org/10.1038/nrn2297
  20. Davidson, K.W., Schwartz, J.E., Kirkland, S.A., Mostofsky, E., Fink, D., Guernsey, D., Shimbo, D., 2009. Relation of inflammation to depression and incident coronary heart disease (from the Canadian Nova Scotia Health Survey [NSHS95] Prospective Population Study). Am J Cardiol. 103, 755-61. http://doi.org/10.1016/j.amjcard.2008.11.035.
  21. Derogatis, L.R., 1975. Brief Symptom Inventory. Baltimore, MD: Clin. Psychom. Res.
  22. Dinarello, C.A., 2018. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 281, 8-27. http://doi.org/10.1111/imr.12621.
  23. Dorrance, A.M., 2007. Interleukin 1-beta (IL-1beta) enhances contractile responses in endothelium-denuded aorta from hypertensive, but not normotensive, rats. Vascul Pharmacol. 47, 160-5. http://doi.org/10.1016/j.vph.2007.05.007.
  24. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctôt, K.L., 2010. A meta-analysis of cytokines in major depression. Biol Psychiatry. 67, 446-57. http://doi.org/10.1016/j.biopsych.2009.09.033.
  25. Elgellaie, A., Larkin, T., Kaelle, J., Mills, J., Thomas, S., 2021. Plasma prolactin is higher in major depressive disorder and females, and associated with anxiety, hostility, somatization, psychotic symptoms and heart rate. Comprehensive Psychoneuroendocrinology, 6. http://doi.org/10.1016/j.cpnec.2021.100049.
  26. Felger, J.C., and Lotrich, F.E., 2013. Inflammatory Cytokines in Depression: Neurobiological Mechanisms and Therapeutic Implications. Neurosci. 246, 199-229. https://doi.org/10.1016/j.neuroscience.2013.04.060
  27. Finnell, J.E., Wood, S.K., 2016. Neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress. Neurobiol Stress. 4, 4:1-14. https://doi.org/10.1016/j.ynstr.2016.04.001.
  28. Gao, Z., Chen, Z., Sun, A., Deng, X. 2019. Gender differences in cardiovascular disease. DOAJ.4. https://doi.org/10.1016/j.medntd.2019.100025.
  29. Global Burden of Disease, 2017. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 392, 1789-1858.
  30. Goldbacher, E., Matthews, K. A., 2007. Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature. Ann Behav Med. 34, 240–52. doi:10.1007/BF02874549
  31. Gowey, M.A., Khodneva, Y., Tison, S.E., Carson, A.P., Cherrington, A.L., Howard, V.J., Safford, M.M., Dutton, G.R., 2019. Depressive symptoms, perceived stress, and metabolic health: The REGARDS study. Int J Obes (Lond). 43, 615-632. https://doi.org/10.1038/s41366-018-0270-3.
  32. Hersey, M., Hashemi, P., Reagan, L. P. 2022. Integrating the monoamine and cytokine hypotheses of depression: Is histamine the missing link?. Eur. J. Neurosci. 55 , 2895–2911. https://doi.org/10.1111/ejn.15392.
  33. Hueston, C.M., Deak, T., 2014. The inflamed axis: the interaction between stress, hormones, and the expression of inflammatory-related genes within key structures comprising the hypothalamic-pituitary-adrenal axis. Physiol Behav.124, 77-91. https://doi.org/10.1016/j.physbeh.2013.10.035.
  34. Karlović, D., Serretti, A., Vrkić, N., Martinac, M., Marčinko, D., 2012. Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res. 198, 74-80. https://doi.org/10.1016/j.psychres.2011.12.007.
  35. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., Walters, E.E., 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62, 593-602. https://doi.org/10.1001/archpsyc.62.6.593.
  36. Klein, S., Flanagan, K., 2016. Sex differences in immune responses. Nat Rev Immunol. 16, 626–638. https://doi.org/10.1038/nri.2016.90
  37. Köhler, C.A., Freitas, T.H., Maes, M., de Andrade, N.Q., Liu, C.S., Fernandes, B.S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., Raison, C.L., Miller, B.J., Lanctôt, K.L., Carvalho, A.F., 2017. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 135,373-387. https://doi.org/10.1111/acps.12698.
  38. Kornstein, S.G., Schatzberg, A.F., Thase, M.E., Yonkers, K.A., McCullough, J.P., Keitner, G.I., Gelenberg, A.J., Davis, S.M., Harrison, W.M., Keller, M.B., 2000. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry. 157, 1445-52. http://doi.org/10.1176/appi.ajp.157.9.1445.
  39. Liu, Y., Ho, R.C., Mak, A., 2012. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 139, 230-9. http://doi.org/10.1016/j.jad.2011.08.003.
  40. Lovibond, S.H., Lovibond, P.F., 1995. Manual for the Depression Anxiety Stress Scales. (2nd. Ed.) Sydney: Psychology Foundation. ISBN 7334-1423-0.
  41. Maes, M., Kubera, M., Obuchowiczwa, E., Goehler, L., Brzeszcz, J., 2011. Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett. 32, 7-24. PMID: 21407167.
  42. Matthews, K.A., Salomon, K., 2003. Hostility predicts the metabolic syndrome risk factors in children and adolescents. Health Psychol. 22, 279–286. http://doi.org/10.4306/pi.2014.11.3.325
  43. McEwen, B.S., 2008. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol.583, 174-185. http://doi.org/10.1016/j.ejphar.2007.11.071
  44. Munjiza, A., Kostic, M., Pesic, D., Gajic, M., Markovic, I., Tosevski, D.L., 2018. Higher concentration of interleukin 6 - A possible link between major depressive disorder and childhood abuse. Psychiatry Res. 264, 26-30. http://doi.org/10.1016/j.psychres.2018.03.072.
  45. Nabi, H., Hall, M., Koskenvuo, M., Singh-Manoux, A., Oksanen, T., Suominen, S., Kivimäki, M. M., Vahtera, J., 2010. Psychological and Somatic Symptoms of Anxiety and Risk of Coronary Heart Disease: The Health and Social Support Prospective Cohort Study. Biol Psychiatry. 67, 378–385 http://doi.org/10.1016/j.biopsych.2009.07.040.
  46. Obermanns, J., Krawczyk, E., Juckel, G., Emons, B. 2021. Analysis of cytokine levels, T regulatory cells and serotonin content in patients with depression. Eur. J. Neurosci. 53 , 3476–3489. https://doi.org/10.1111/ejn.15205
  47. O’Connor, M.F., Motivala, S.J., Valladares, E.M., Olmstead, R., Irwin, M.R., 2007. Sex differences in monocyte expression of IL-6: role of autonomic mechanisms. Am J Physiol Regul Integr Comp Physiol. 293, R145-51. http://doi.org/10.1152/ajpregu.00752.2006.
  48. Ojike, N., Sowers, J. R., Seixas, A., Ravenell, J., Rodriguez-Figueroa, G., Awadallah, M., Zizi, F., Jean-Louis, G., Ogedegbe, O., Samy I. McFarlane, S. I., 2016. Psychological Distress and Hypertension: Results from the National Health Interview Survey for 2004–2013. Cardiorenal Med. 6, 198–208. http://doi.org/0.1159/000443933.
  49. Olafiranye, O., Jean-Louis, G., Zizi, F., Nunes, J., Vincent, M., 2011. Anxiety and cardiovascular risk: Review of Epidemiological and Clinical Evidence. Mind & brain : the journal of psychiatry, 2, 32–37.
  50. Osimo, E.F., Pillinger, T., Rodriguez, I.M., Khandaker, G.M., Pariante, C.M., Howes, O.D., 2020. Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun. 87, 901-909. http://doi.org/10.1016/j.bbi.2020.02.010.
  51. Pittig. A., Arch, J.J., Lam, C.W., Craske, M.G., 2013. Heart rate and heart rate variability in panic, social anxiety, obsessive-compulsive, and generalized anxiety disorders at baseline and in response to relaxation and hyperventilation. Int J Psychophysiol. 87, 19-27. http://doi.org/10.1016/j.ijpsycho.2012.10.012
  52. Postal, M., Lapa, A. T., Sinicato, N. A., de Oliveira Peliçari, K., Peres, F. A., Costallat, L. T., Fernandes, P. T., Marini, R., Appenzeller, S., 2016. Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus. J. neuroinflammation, 13, 5. https://doi.org/10.1186/s12974-015-0471-9
  53. Quitkin, F.M., Stewart, J.W., McGrath, P.J., Taylor, B.P., Tisminetzky, M.S., Petkova, E., Chen, Y., Ma, G., Klein, D. F. 2002. Are there differences between women’s and men’s antidepressant responses? Am J Psychiatry. 159, 1848–1854. https://doi.org/10.1176/appi.ajp.159.11.1848
  54. Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., Pollmächer, T., 2001. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 58 :445-52. https://doi.org/10.1001/archpsyc.58.5.445.
  55. Ridker, M., Rane, M., 2021. Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease. Circ res. 128, 1728–1746. https://doi.org/10.1161/CIRCRESAHA.121.319077
  56. Ridker, P.M., Hennekens, C.H., Buring, J.E., Rifai, N., 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342, 836-43. https://doi.org/10.1056/NEJM200003233421202.
  57. Schmidt, F.M., Lichtblau, N., Minkwitz, J., Chittka, T., Thormann, J., Kirkby, K.C., Sander, C., Mergl, R., Faßhauer, M., Stumvoll, M., Holdt, L.M., Teupser, D., Hegerl, U., Himmerich, H., 2014. Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J Psychiatr Res. 55, 29-34. http://doi.org/10.1016/j.jpsychires.2014.04.021.
  58. Seney, M.L., Glausier, J., Sibille, E., 2021. Large-Scale Transcriptomics Studies Provide Insight Into Sex Differences in Depression. Biol Psychiatry. http://doi.org/10.1016/j.biopsych.2020.12.025.
  59. Sheehan, D.V., 2015. Mini International Neuropsychiatric Interview 7.0. FL: Medical Outcomes Systems. Jacksonville.
  60. Shelton, R.C., Falola, M., Li, L., Zajecka, J., Fava, M., Papakostas, G. I., 2015. The pro-inflammatory profile of depressed patients is (partly) related to obesity. J psychiatr. Res. 70, 91–97. https://doi.org/10.1016/j.jpsychires.2015.09.001
  61. Simon, G.E., Ludman, E.J., Linde, J.A., Operskalski, B.H., Ichikawa, L., Rohde, P., Finch, E.A., Jeffery, R.W., 2007. Association between obesity and depression in middle-aged women. Gen Hosp Psychiatry. 30, 32-9. http://doi.org/10.1016/j.genhosppsych.2007.09.001.
  62. Spicer, J., Chamberlain. K., 1996. Cynical hostility, anger, and resting blood pressure. J Psychosom Res. 40, 359-68. http://doi.org/10.1016/0022-3999(95)00546-3.
  63. Srivastava, A.K., 2012. Challenges in the treatment of cardiometabolic syndrome. Indian J. pharmacol. 44, 155–156. https://doi.org/10.4103/0253-7613.93579.
  64. Suarez, E.C., Bates, M.P., Harralson, T.L., 1998. The relation of hostility to lipids and lipoproteins in women: evidence for the role of antagonistic hostility. Ann Behav Med. 20, 59-63. https://doi.org/10.1007/BF02884449.
  65. Suarez, E.C., Krishnan, R.R., Lewis, J. G., 2003. The Relation of Severity of Depressive Symptoms to Monocyte-Associated Proinflammatory Cytokines and Chemokines in Apparently Healthy Men, Psychosom. Med. 65, 362-368. https://doi.org/10.1097/01.PSY.0000035719.79068.2B
  66. Suarez, E.C., Lewis, J.G., Krishnan, R.R., Young, K.H., 2004. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology. 29,1119-28. https://doi.org/10.1016/j.psyneuen.2004.01.002.
  67. Takahashi, A., Flanigan, M.E., McEwen, B.S., Russo, S.J., 2018. Aggression, Social Stress, and the Immune System in Humans and Animal Models. Front Behav Neurosci. 22,12:56. https://doi.org/10.3389/fnbeh.2018.00056.
  68. Tuglu, C., Kara, S.H., Caliyurt, O., Vardar, E., Abay, E., 2003. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl). 170, 429-33. https://doi.org/10.1007/s00213-003-1566-z.
  69. Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., Cella, D., Krishnan, R., 2006. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 367, 29-35. https://doi.org/10.1016/S0140-6736(05)67763-X.
  70. Um, J.Y., Rim, H.K., Kim, S.J., Kim, H.L., Hong, S.H., 2011. Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and mice. PLoS One. 6. https://doi.org/10.1371/journal.pone.0029524.
  71. Urschel, K., Cicha, I., 2015. TNF-α in the cardiovascular system: from physiology to therapy. Int. J. Interferon, Cytokine Mediat. Res. 7, 9-25. https://doi.org/10.2147/IJICMR.S64894
  72. Voronov, E., Dotan, S., Krelin, Y., Song, X., Elkabets, M., Carmi, Y., Rider, P., Idan, C., Romzova, M., Kaplanov, I., Apte, R.N., 2013. Unique Versus Redundant Functions of IL-1α and IL-1β in the Tumor Microenvironment. Front Immunol. 8, 4:177. https://doi.org/10.3389/fimmu.2013.00177.
  73. Wegner, A., Benson, S., Rebernik, L., Spreitzer, I., Jäger, M., Schedlowski, M., Elsenbruch, S., Engler, H., 2017. Sex differences in the pro-inflammatory cytokine response to endotoxin unfold in vivo but not ex vivo in healthy humans. Innate Immun. 23, 432-439. https://doi.org/10.1177/1753425917707026.
  74. Wong, J.M., Na, B., Regan, M.C., Whooley, M.A., 2013. Hostility, health behaviors, and risk of recurrent events in patients with stable coronary heart disease: findings from the Heart and Soul Study. J Am Heart Assoc. 2, e000052. https://doi.org/10.1161/JAHA.113.000052.
  75. World Health Organisation, 2017. Cardiovascular diseases. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/ (09 June 2021, date last accessed).